Axios

Tens of millions of dollars are fueling ads across platforms to push abortion rights measures that are expected to be on the ballot in Arizona, Nevada and Montana this year, according to AdImpact data.

Why it matters: Those same states could determine the next president and control of the Senate. Democrats hope having abortion on the ballot will keep the focus on their most potent issue — and turn out much-needed voters.

The Food and Drug Administration is warning that more ground cinnamon products contain "elevated levels of lead" that may be unsafe.

Why it matters: The federal agency is advising consumers to "stop using and dispose of" the recalled ground cinnamon products.

The federal government is pouring money into getting more farmworkers vaccinated to prevent them from being infected by the seasonal flu and bird flu viruses at the same time.

Why it matters: Officials said the mitigation efforts part of a wider effort to reduce a "theoretical" risk that the viruses could mix and become more transmissible in humans.

The emotional lives of most American kids and teens are complex, with sadness, anxiety and stress intermingled with happiness, according to a Gallup-Walton Family Foundation survey out today.

Why it matters: The survey provides a nuanced view of Gen Z's emotional lives and how that group copes with stressors amid growing concerns of a youth mental health crisis in America.

What they found: Negative feelings were more common among girls and teenagers between 16-18 years old, the poll of 1,625 kids and their parents or guardians found.

Private Medicare plans now cover more than half of Medicare beneficiaries, but how well they actually serve people differs from county to county.

Why it matters: Medicare enrollees living in communities of color and with high rates of poverty had less access to top-rated Medicare Advantage plans last year than those living in wealthier places that are majority white.

The Olympic men's individual triathlon race that was due to be held in Paris' River Seine Tuesday was rescheduled to the following day due to swimming safety concerns, per a statement first shared by governing body World Triathlon.

Why it matters: It's a blow to organizers who stepped up efforts to get the French capital's river clean and safe for swimming so it could play a central role in the Olympics after decades of pollution.

Caregivers power the U.S. economy, but insufficient investment in the care system forces families — especially women — to bear unsustainable costs.

What you need to know: A recent survey commissioned by Pivotal Ventures and Bipartisan Policy Center Action, and conducted by Morning Consult, reveals the widespread demand for caregiving solutions.

A small group of people around the world truly don't need more than four to six hours of sleep a night, thanks to a rare gene.

Why it matters: Very few people are natural short sleepers, but deeper study of the way their bodies and brains work offers valuable lessons for all of us.

The Food and Drug Administration on Monday approved a blood test to detect colorectal cancer in individuals age 45 and older, adding another screening option for the second-most common cause of U.S. cancer deaths.

Why it matters: More than 1 out of 3 eligible Americans don't complete screening methods such as colonoscopy or a stool test, and a simple blood draw for the condition could be incorporated into routine physicals.

One of the strictest abortion bans in the nation came into force in Iowa on Monday.

Why it matters: Most abortions are now prohibited after about six weeks of pregnancy, with exceptions in the cases of rape, incest or to save the life of the patient.

Prospective competitors to blockbuster weight-loss drugs are heading toward commercialization and posing a threat to industry behemoths Novo Nordisk and Eli Lilly, Axios' Nathan Bomey writes.

Why it matters: Booming sales of Novo Nordisk's Ozempic and Wegovy and Eli Lilly's Mounjaro and Zepbound have led to widespread shortages of GLP-1 treatments.

Driving the news: San Diego-based Viking Therapeutics is accelerating development of its own injectable GLP-1 treatment after receiving positive feedback from the Food and Drug Administration.

• Trial results showing a 15% reduction in body weight after 13 weeks mean the treatment could make it to the market a year ahead of schedule, BTIG analyst Justin Zelin wrote in a research note.

🛑 European drug regulators rejected Biogen and Eisai's Alzheimer's treatment Leqembi, saying its effect on delaying cognitive decline doesn't outweigh the risk of serious side effects. (CNBC)

👨‍⚕️ Humana is leasing clinical space in Walmart Supercenter stores in Florida, Georgia, Missouri and Texas after the retail giant shuttered its health centers and virtual care business. (Healthcare Dive)

🏝️ As doctors leave Puerto Rico in droves, a rapper is trying to fill the gaps and help treat underserved, remote communities. (AP)

Almost 1 in 4 American adults with frequent mental distress reported not seeing a doctor because of the cost, Mental Health America found in a new survey based on 2022 federal data.

Why it matters: Delayed or forgone treatment for mental disorders is often linked to insurance status and medical debt, and is fueling a treatment gap that cuts across demographic groups.

The Biden administration is overhauling its health IT bureaucracy to address the proliferation of cyberattacks on the sector and the growth of data and artificial intelligence in medical settings.

Why it matters: The goals include setting an AI policy and strategy for HHS and streamlining critical infrastructure protection within the Administration for Strategic Preparedness and Response, or ASPR, per a notice to be published in the Federal Register on Monday.

There's growing evidence that blood tests can accurately diagnose Alzheimer's disease and pave the way for earlier treatment of more patients.

Why it matters: Making Alzheimer's easier to detect is seen as crucial now that new drugs that slow the disease's progression are coming onto the market.